NCT02105272View on ClinicalTrials.gov

Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

237

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
GlaucomaOcular Hypertension
Interventions
DRUG

OPC-1085EL ophthalmic solution

DRUG

Latanoprost ophthalmic solution

Trial Locations (1)

Unknown

Kansai Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY